|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 116, Issue 3 625-637, Copyright © 1992 by Company of Biologists
JOURNAL ARTICLES |
Y Sumi, MA Dent, DE Owen, PJ Seeley and RJ Morris
Norman and Sadie Lee Centre, Laboratory of Neurobiology, National Institute for Medical Research, London, UK.
Tissue and urokinase-type plasminogen activators are serine proteases with highly restricted specificity, their best characterised role being to release the broad specificity protease plasmin from inactive plasminogen. It has frequently been suggested that these, and similar proteases, are involved in axonal growth and tissue remodelling associated with neural development. To help define what this role might be, we have studied the expression of the plasminogen activators in developing rat nervous tissue. Urokinase-type plasminogen activator mRNA is strongly expressed by many classes of neurons in peripheral and central nervous system. We have analysed its appearance in spinal cord and sensory ganglia, and found the mRNA is detectable by in situ hybridisation very early in neuronal development (by embryonic day 12.5), at a stage compatible with it playing a role in axonal or dendritic growth. Tissue plasminogen activator mRNA, on the other hand, is expressed only by cells of the floor plate in the developing nervous system, from embryonic day 10.5 and thereafter. Immunohistochemical and enzymatic analysis showed that active tissue plasminogen activator is produced by, and retained within, the floor plate. A mechanism is suggested by which high levels of tissue plasminogen activator produced by the stationary cells of the floor plate could influence the direction of growth of commissural axons as they pass through this midline structure.
This article has been cited by other articles:
![]() |
O. Froy, N. Chapnik, and R. Miskin Long-lived {alpha}MUPA transgenic mice exhibit pronounced circadian rhythms Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1017 - E1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fernandez-Monreal, J. P. Lopez-Atalaya, K. Benchenane, M. Cacquevel, F. Dulin, J.-P. Le Caer, J. Rossier, A.-C. Jarrige, E. T. MacKenzie, N. Colloc'h, et al. Arginine 260 of the Amino-terminal Domain of NR1 Subunit Is Critical for Tissue-type Plasminogen Activator-mediated Enhancement of N-Methyl-D-aspartate Receptor Signaling J. Biol. Chem., December 3, 2004; 279(49): 50850 - 50856. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, K. Tsuji, S.-R. Lee, M. Ning, K. L. Furie, A. M. Buchan, and E. H. Lo Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke Stroke, November 1, 2004; 35(11_suppl_1): 2726 - 2730. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Junge, T. Sugawara, G. Mannaioni, S. Alagarsamy, P. J. Conn, D. J. Brat, P. H. Chan, and S. F. Traynelis The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia PNAS, October 28, 2003; 100(22): 13019 - 13024. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Siconolfi and N. W. Seeds Induction of the Plasminogen Activator System Accompanies Peripheral Nerve Regeneration after Sciatic Nerve Crush J. Neurosci., June 15, 2001; 21(12): 4336 - 4347. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Siconolfi and N. W. Seeds Mice Lacking tPA, uPA, or Plasminogen Genes Showed Delayed Functional Recovery after Sciatic Nerve Crush J. Neurosci., June 15, 2001; 21(12): 4348 - 4355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Gingrich, C. E. Junge, P. Lyuboslavsky, and S. F. Traynelis Potentiation of NMDA Receptor Function by the Serine Protease Thrombin J. Neurosci., June 15, 2000; 20(12): 4582 - 4595. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakagami, K. Abe, N. Nishiyama, and N. Matsuki Laminin Degradation by Plasmin Regulates Long-Term Potentiation J. Neurosci., March 1, 2000; 20(5): 2003 - 2010. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sugiura, L. Ma, B. Sun, H. Shimada, W. E. Laug, R. C. Seeger, and Y. A. DeClerck The Plasminogen-Plasminogen Activator (PA) System in Neuroblastoma: Role of PA Inhibitor-1 in Metastasis Cancer Res., March 1, 1999; 59(6): 1327 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Lochner, M. Kingma, S. Kuhn, C. D. Meliza, B. Cutler, and B. A. Scalettar Real-Time Imaging of the Axonal Transport of Granules Containing a Tissue Plasminogen Activator/Green Fluorescent Protein Hybrid Mol. Biol. Cell, September 1, 1998; 9(9): 2463 - 2476. [Abstract] [Full Text] |
||||
![]() |
S. R. Krueger, G.-P. Ghisu, P. Cinelli, T. P. Gschwend, T. Osterwalder, D. P. Wolfer, and P. Sonderegger Expression of Neuroserpin, an Inhibitor of Tissue Plasminogen Activator, in the Developing and Adult Nervous System of the Mouse J. Neurosci., December 1, 1997; 17(23): 8984 - 8996. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Scarisbrick, M. D. Towner, and P. J. Isackson Nervous System-Specific Expression of a Novel Serine Protease: Regulation in the Adult Rat Spinal Cord by Excitotoxic Injury J. Neurosci., November 1, 1997; 17(21): 8156 - 8168. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Kury, N Schaeren-Wiemers, and D Monard Protease nexin-1 is expressed at the mouse met-/mesencephalic junction and FGF signaling regulates its promoter activity in primary met-/mesencephalic cells Development, January 3, 1997; 124(6): 1251 - 1262. [Abstract] [PDF] |
||||
![]() |
B Murugasu-Oei, V Rodrigues, X Yang, and W Chia Masquerade: a novel secreted serine protease-like molecule is required for somatic muscle attachment in the Drosophila embryo. Genes & Dev., January 15, 1995; 9(2): 139 - 154. [Abstract] [PDF] |
||||
![]() |
O Lefebvre, C Regnier, M. Chenard, C Wendling, P Chambon, P Basset, and M. Rio Developmental expression of mouse stromelysin-3 mRNA Development, January 4, 1995; 121(4): 947 - 955. [Abstract] [PDF] |
||||
![]() |
P. Carroll, S. Tsirka, W. Richards, M. Frohman, and S Strickland The mouse tissue plasminogen activator gene 5' flanking region directs appropriate expression in development and a seizure-enhanced response in the CNS Development, January 11, 1994; 120(11): 3173 - 3183. [Abstract] [PDF] |
||||
![]() |
I. M. Mansuy, H. van der Putten, P. Schmid, M. Meins, F. M. Botteri, and D. Monard Variable and multiple expression of Protease Nexin-1 during mouse organogenesis and nervous system development Development, December 1, 1993; 119(4): 1119 - 1134. [Abstract] [PDF] |
||||
![]() |
P. Carroll, W. Richards, A. Darrow, J. Wells, and S Strickland Preimplantation mouse embryos express a cell surface receptor for tissue-plasminogen activator Development, January 9, 1993; 119(1): 191 - 198. [Abstract] [PDF] |
||||
![]() |
V. Tzarfaty-Majar, R. Lopez-Alemany, Y. Feinstein, L. Gombau, O. Goldshmidt, E. Soriano, P. Munoz-Canoves, and A. Klar Plasmin-mediated Release of the Guidance Molecule F-spondin from the Extracellular Matrix J. Biol. Chem., July 20, 2001; 276(30): 28233 - 28241. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Jacovina, F. Zhong, E. Khazanova, E. Lev, A. B. Deora, and K. A. Hajjar Neuritogenesis and the Nerve Growth Factor-induced Differentiation of PC-12 Cells Requires Annexin II-mediated Plasmin Generation J. Biol. Chem., December 21, 2001; 276(52): 49350 - 49358. [Abstract] [Full Text] [PDF] |
||||